Overall, our findings demonstrate that the interaction between CD21 and gp350 is effectively captured by the biosensor, enabling the potential early detection of asymptomatic EBV infections, particularly in younger populations. This evidence concerns the gene CR2 and Epstein-Barr virus infection.